Business Description
InnoCan Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA45783P1027
Share Class Description:
INNPF: Ordinary SharesCompare
Compare
Traded in other countries / regions
INNO.CanadaIP4.GermanyINNPF.USA IPO Date
2020-11-24Description
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 115.82 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 35.4 | |||||
| 3-Year EPS without NRI Growth Rate | 15.1 | |||||
| 3-Year FCF Growth Rate | 10.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.79 | |||||
| 9-Day RSI | 22.64 | |||||
| 14-Day RSI | 29.07 | |||||
| 6-1 Month Momentum % | -10.64 | |||||
| 12-1 Month Momentum % | 46.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.68 | |||||
| Quick Ratio | 1.99 | |||||
| Cash Ratio | 1.53 | |||||
| Days Inventory | 317.02 | |||||
| Days Sales Outstanding | 0.45 | |||||
| Days Payable | 44.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.5 | |||||
| Shareholder Yield % | -2.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.73 | |||||
| Operating Margin % | -27.99 | |||||
| Net Margin % | -34.6 | |||||
| FCF Margin % | -28.92 | |||||
| ROE % | -93.09 | |||||
| ROA % | -71.15 | |||||
| ROIC % | -201.56 | |||||
| ROC (Joel Greenblatt) % | -570.01 | |||||
| ROCE % | -79.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.94 | |||||
| PB Ratio | 13.33 | |||||
| Price-to-Tangible-Book | 20.81 | |||||
| EV-to-EBIT | -13.44 | |||||
| EV-to-EBITDA | -13.55 | |||||
| EV-to-Revenue | 3.99 | |||||
| EV-to-FCF | -13.76 | |||||
| Price-to-Net-Current-Asset-Value | 20.81 | |||||
| Price-to-Net-Cash | 20.81 | |||||
| Earnings Yield (Greenblatt) % | -7.44 | |||||
| FCF Yield % | -6.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INNPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InnoCan Pharma Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13.657 | ||
| EPS (TTM) ($) | -0.017 | ||
| Beta | 0.43 | ||
| Volatility % | 90.29 | ||
| 14-Day RSI | 29.07 | ||
| 14-Day ATR ($) | 0.001654 | ||
| 20-Day SMA ($) | 0.21864 | ||
| 12-1 Month Momentum % | 46.85 | ||
| 52-Week Range ($) | 0.143 - 0.3545 | ||
| Shares Outstanding (Mil) | 280.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InnoCan Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InnoCan Pharma Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
InnoCan Pharma Corp Frequently Asked Questions
What is InnoCan Pharma Corp(INNPF)'s stock price today?
The current price of INNPF is $0.21. The 52 week high of INNPF is $0.35 and 52 week low is $0.14.
When is next earnings date of InnoCan Pharma Corp(INNPF)?
The next earnings date of InnoCan Pharma Corp(INNPF) is .
Does InnoCan Pharma Corp(INNPF) pay dividends? If so, how much?
InnoCan Pharma Corp(INNPF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers